top of page
BIOTECH
Efficient, precise, and expansive, RAvIN redefines nucleoside synthesis to power next-generation RNA therapeutics
RAvINs groundbreaking chemistry streamlines synthesis and maximizes the chemical diversity required to create clinically viable RNA medicines.
Streamlined synthesis of med chem ready nucleoside cores means:
Enhanced Drug Performance​
-
Expanded chemical space
-
Improved ADMET profile
-
Extrahepatic distribution
-
BBB crossing
Enhanced Manufacturing
-
Lowered production costs
-
Greener route to RNA therapeutics
-
Single-component, homogeneous chemical entities displaying precise stoichiometry
-
Faster manufacture = personalized medicine enabling
Example of application: Six high-value nucleoside analogs, produced with the RAvIN platform vs. conventional methods
NB = Thymine
Business Title
With its expanding library of nucleoside analogs, RAvIN allows for rapid, rational, and unprecedented fine-tuning of RNA medicines to address ADMET issues, a significant advantage over conventional modifications that often lead to attrition.
Conventional
modifications
Cloudburst-enabled
modifications
VS
bottom of page